We observed no significant difference in TRAF6 expression between the tested groups: no coronary heart disease (no CHD), stable coronary heart disease (CHD) and acute coronary syndrome (ACS), corroborating our findings obtained in mice. This evidence concerns the gene TRAF6 and acute coronary syndrome.